Market Access for International Medical Cannabis Producers
TONNEX supports international medical cannabis producers in preparing their products for the German and European pharmaceutical market.
For producers outside the EU, market access is not only a commercial question. It is a regulatory, pharmaceutical and operational challenge. Products must meet strict requirements for documentation, quality control, manufacturing standards, testing, stability and batch release.
TONNEX provides the infrastructure, expertise and process control required to bring medical cannabis products into the EU market through EU-GMP manufacturing and batch release in Germany.
For international producers, TONNEX is the regulatory gateway to Europe.
EU-GMP Cannabis Contract Manufacturing & Batch Release in Germany
Entering the German and European medical cannabis market requires more than a high-quality product. It requires a compliant pharmaceutical process, reliable documentation and a release structure that meets EU expectations.
TONNEX supports producers with key services required for market-ready medical cannabis products in Europe:
EU-GMP manufacturing and finishing
QP batch release in Germany
Quality assurance and document review
Laboratory testing and stability studies
GDP logistics and distribution structures
The objective is clear: to transform medical cannabis products from outside the EU into pharmaceutical products ready for the German and European market.
Who We Work With
TONNEX works with international producers, manufacturers and suppliers of medical cannabis seeking access to Germany and Europe.
Typical situations include:
- Producers with high-quality cannabis flower or extracts who need a German partner for EU-GMP manufacturing, testing and batch release.
- Manufacturers operating under GACP or local GMP standards who require a structured pathway into the European pharmaceutical market.
- International companies looking for a reliable partner for QP release, quality control, stability data, GDP logistics and market access in Germany.
This is where TONNEX comes in.
Why Germany?
Germany is one of the most important medical cannabis markets in Europe. At the same time, regulatory expectations are high.
For international producers, this creates a clear requirement: a German partner who understands pharmaceutical processes, documentation, quality assurance and batch release.
TONNEX combines operational infrastructure in Germany with regulatory and pharmaceutical process competence. The result is a structured route into the European market.
GMP Gateway to the EU Market
TONNEX provides international medical cannabis producers with a structured gateway to the German and European pharmaceutical market.
Through EU-GMP manufacturing and batch release in Germany, quality control, laboratory services and GDP logistics, TONNEX helps transform international medical cannabis products into market-ready pharmaceutical goods for Europe.
1
Contact & Introductory Call
We clarify the product, origin, target market, regulatory status and basic requirements.
2
Document Review
TONNEX reviews existing documentation, manufacturing information, quality data and regulatory starting points.
3
Offer & Agreements
Based on product and process requirements, we define scope, timeline and contractual structure.
4
Audit & Product Validation
Relevant processes, documentation and quality parameters are reviewed and prepared for operational implementation.
5
Operational Start
After alignment, the cooperation starts with clear processes for manufacturing, testing, batch release and logistics.
TONNEX Makes Medical Cannabis Products Market-Ready for Europe
International producers do not only need access to Europe. They need structure, pharmaceutical reliability and regulatory clarity.
TONNEX connects non-EU production with the German pharmaceutical market. High-quality cannabis products become market-ready medical products through controlled processes, quality assurance and EU-GMP manufacturing and release in Germany.
TONNEX – EU-GMP manufacturing and batch release in Germany for international medical cannabis producers.
